切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2021, Vol. 10 ›› Issue (02) : 216 -219. doi: 10.3877/cma.j.issn.2095-3224.2021.02.017

所属专题: 经典病例 文献

病例报道

直肠腺瘤合并原发性肝脏神经内分泌癌一例
李江斌1, 罗年安1, 徐岩1, 陈亚峰1, 董瑞1,()   
  1. 1. 710038 西安,中国人民解放军空军军医大学唐都医院普通外科
  • 收稿日期:2020-09-24 出版日期:2021-04-25
  • 通信作者: 董瑞
  • 基金资助:
    陕西省2020年重点研发计划项目(2020SF-067)

A case of rectal adenoma with primary hepatic neuroendocrine carcinoma

Jiangbin Li1, Nian'an Luo1, Yan Xu1, Yafeng Chen1, Rui Dong1,()   

  1. 1. Department of General Surgery, the Second Affiliated Hospital, the Air Force Military Medical University, Xi'an 710038, China
  • Received:2020-09-24 Published:2021-04-25
  • Corresponding author: Rui Dong
引用本文:

李江斌, 罗年安, 徐岩, 陈亚峰, 董瑞. 直肠腺瘤合并原发性肝脏神经内分泌癌一例[J/OL]. 中华结直肠疾病电子杂志, 2021, 10(02): 216-219.

Jiangbin Li, Nian'an Luo, Yan Xu, Yafeng Chen, Rui Dong. A case of rectal adenoma with primary hepatic neuroendocrine carcinoma[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2021, 10(02): 216-219.

原发性肝脏神经内分泌癌(PHNEC)较罕见,临床症状、体征、超声及影像学检查均不具特异性,病理表现和免疫表型是确诊的主要依据。本例患者因直肠和肝脏特殊的影像学表现,入院初考虑直肠癌伴肝转移,后经病理和免疫组化确诊PHNEC。该病例提示我们临床工作中应警惕因经验主义引起的误诊,应重视病理学诊断结果。

Primary hepatic neuroendocrine carcinoma (PHNEC) is relatively rare. The clinical symptoms, signs, and ultrasound images are not specific. Diagnosis is mainly based on pathological manifestations and immunophenotyping analysis. This individual was initially diagnosed with rectal cancer with liver metastasis because of unclear and inconclusive imaging examination results. The biopsy and immunohistochemical examinations suggested PHNEC. This case suggests that we should be alert to the misdiagnosis caused by empiricism and pay attention to the pathological diagnosis results in clinical work.

图1 肝脏和直肠PET/CT图像。1A:肝实质内见多发类圆形低密度影伴放射性摄取增高,1B:直肠后壁见结节状软组织密度影伴代谢性摄取增高
图2 肝脏病理和免疫组化。2A:异型细胞巢(HE染色,40倍);2B~2D:CD56、CgA、Syn阳性(10倍)
1
Yang K. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature[J]. World J Gastroenterol, 2015, 21(10): 3132-3138.
2
Chen RW, Qiu MJ, Chen Y, et al. Analysis of the clinicopathological features and prognostic factors of primary hepatic neuroendocrine tumors[J]. Oncol Lett, 2018, 15(6): 8604-8610.
3
Wang L, Liu K, Lin G, et al. Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology[J]. Cancer Imaging, 2015, 15(1): 13.
4
Yang K, Cheng YS, Yang JJ, et al. Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations[J]. Cancer Imaging, 2017, 17(1): 20.
5
Orlefors H, Sundin A, Garske U, et al. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography[J]. J Clin Endocrinol Metab, 2005, 90(6): 3392-3400.
6
Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging[J]. Semin Nucl Med, 2002, 32(2): 84-91.
7
Tamm EP, Kim EE, Ng CS. Imaging of neuroendocrine tumors[J]. Hematol Oncol Clin North Am, 2007, 21(3): 409-432.
8
Ibrahim ME, Abadeer K, Zhai QJ, et al. Primary hepatic neuroendocrine tumor with unusual thyroid follicular-like morphologic characteristics[J]. Case Rep Pathol, 2017, 2017: 7931975.
9
Qiu MJ, Chen YB, Bi NR, et al. Comparative clinical analysis of gastroenteropancreatic neuroendocrine carcinomas with liver metastasis and primary hepatic neuroendocrine carcinomas[J]. Dis Markers, 2018, 2018: 9191639.
10
Pastrián LG, Ruz-Caracuel I, Gonzalez RS. Giant primary neuroendocrine neoplasms of the liver: report of 2 cases with molecular characterization[J]. Int J Surg Pathol, 2019, 27(8): 893-899.
11
Rickman DS, Beltran H, Demichelis F, et al. Biology and evolution of poorly differentiated neuroendocrine tumors[J]. Nat Med, 2017, 23(6): 1-10.
12
Patel P, Galoian K. Molecular challenges of neuroendocrine tumors[J]. Oncol Lett, 2018, 15(3): 2715-2725.
13
Uri I, Avniel-Polak S, Gross DJ, et al. Update in the therapy of advanced neuroendocrine tumors[J]. Curr Treat Options Oncol, 2017, 18(12): 72.
14
Severi S, Grassi I, Nicolini S, et al. Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life[J]. Onco Targets Ther, 2017, 10: 551-557.
15
Okumura Y, Kohashi K, Wang H, et al. Combined primary hepatic neuroendocrine carcinoma and hepatocellular carcinoma with aggressive biological behavior (adverse clinical course): A case report[J]. Pathol Res Pract, 2017, 213(10): 1322-1326.
16
Zhao Z, Wang J, Ugwuowo UC, et al. Primary hepatic neuroendocrine carcinoma: report of two cases and literature review[J]. BMC Clin Pathol, 2018, 18(1): 3-10.
17
Faggiano A, Lo Calzo F, Pizza G, et al. The safety of available treatments options for neuroendocrine tumors[J]. Expert Opin Drug Saf, 2017, 16(10): 1149-1161.
18
Elizabeth M, Kathleen O, Maurine T, et al. Primary hepatic neuroendocrine carcinoma treated with doxorubicin and cyclophosphamide in a dog[J]. J Am Anim Hosp Assoc, 2019, 55(3): e55305.
[1] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[2] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[3] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[4] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[7] 郑民华, 蒋天宇, 赵轩, 马君俊. 中国腹腔镜直肠癌根治术30年发展历程与未来[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 591-595.
[8] 池畔, 黄胜辉. 中国腹腔镜直肠癌根治术30年来的巨大进步[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 596-600.
[9] 李明, 屠松, 闫鹏, 钱军, 高鹏程, 许文山, 杨发英, 胡振涛, 单永玮. 应用前列腺电切镜引导置管治疗直肠低位吻合口漏研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 603-606.
[10] 李玲, 刘亚, 李培玲, 张秀敏, 李萍. 直肠癌患者术后肠道菌群的变化与抑郁症相关性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 607-610.
[11] 赵梓竣, 兰运升. 改良一针法末端回肠造口术对低位直肠癌保肛术后应激反应及安全性的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 611-614.
[12] 吴胜伟, 王志伟, 陈贵进, 刘序, 吴晓翔. 系膜肥厚低位直肠癌患者改良NOSES Ⅰ式手术的临床效果评价[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 615-618.
[13] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[14] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[15] 周学锋, 董哲毅, 冯哲, 蔡广研, 陈香美. 糖尿病肾脏疾病中西医结合诊疗指南计划书[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 301-305.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?